Loading insider details...
Beta
Latest Form 4 (May 27, 2026): Tax Withholding of 4,036 SGMO shares, $703.47.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 27, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 4,036 | $703.47 |
| Apr 23, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Sale | 345,942 | $89.2K |
| Apr 3, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Grant/Award | 800,000 | n/a |
| Feb 27, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 2,063 | $974.77 |
| Jan 26, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 36,676 | $14.6K |
| Nov 26, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 2,544 | $1.1K |
| Oct 24, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 43,741 | $28.9K |
| Aug 26, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 1,792 | $1.1K |
| Jul 24, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 31,866 | $15.3K |
| May 28, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 1,792 | $848.15 |